1 Stock Under $50 on Our Watchlist and 2 to Turn Down
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they're not immune to volatility as many lack the scale advantages of their larger peers.
Luckily for you, our mission at StockStory is to help you make money and avoid losses by sorting the winners from the losers. That said, here is one stock under $50 with huge potential and two best left ignored.
Share Price: $39.18
Operating as a critical behind-the-scenes partner for complex technology products since 1979, Benchmark Electronics (NYSE:BHE) provides advanced manufacturing, engineering, and technology solutions for original equipment manufacturers across aerospace, medical, industrial, and technology sectors.
Why Should You Dump BHE?
Customers postponed purchases of its products and services this cycle as its revenue declined by 4.1% annually over the last two years
Low free cash flow margin of 0.6% for the last five years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders
Low returns on capital reflect management's struggle to allocate funds effectively
Benchmark's stock price of $39.18 implies a valuation ratio of 16x forward price-to-earnings. Check out our free in-depth research report to learn more about why BHE doesn't pass our bar.
Share Price: $18.06
Operating one of the largest healthcare group purchasing organizations in the United States with over 4,350 hospital members, Premier (NASDAQ:PINC) is a technology-driven healthcare improvement company that helps hospitals, health systems, and other providers reduce costs and improve clinical outcomes.
Why Are We Out on PINC?
Products and services are facing significant end-market challenges during this cycle as sales have declined by 6.9% annually over the last two years
Sales are projected to tank by 15.9% over the next 12 months as its demand continues evaporating
Waning returns on capital from an already weak starting point displays the inefficacy of management's past and current investment decisions
Premier is trading at $18.06 per share, or 15.2x forward price-to-earnings. Read our free research report to see why you should think twice about including PINC in your portfolio, it's free.
Share Price: $27.65
Originally launched with a focus on stigmatized conditions like hair loss and sexual health, Hims & Hers Health (NYSE:HIMS) operates a consumer-focused telehealth platform that connects patients with healthcare providers for prescriptions and wellness products.
Why Is HIMS on Our Radar?
Customer trends over the past two years show it's maintaining a steady flow of new contracts that can potentially increase in value over time
Free cash flow margin expanded by 17.9 percentage points over the last five years, providing additional flexibility for investments and share buybacks/dividends
Rising returns on capital show the company is starting to reap the benefits of its past investments
At $27.65 per share, Hims & Hers Health trades at 28.6x forward price-to-earnings. Is now the right time to buy? See for yourself in our comprehensive research report, it's free.
With rates dropping, inflation stabilizing, and the elections in the rearview mirror, all signs point to the start of a new bull run - and we're laser-focused on finding the best stocks for this upcoming cycle.
Put yourself in the driver's seat by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years.
Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Sterling Infrastructure (+1,096% five-year return). Find your next big winner with StockStory today for free.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
18 minutes ago
- Business Wire
ZEO Investors Have Opportunity to Join Zeo Energy Corp. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zeo Energy Corp. ('Zeo' or 'the Company') (NASDAQ: ZEO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Zeo announced on May 29, 2025, that it had received "a notice . . . from Nasdaq on May 22, 2025, notifying the Company that it is not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) because the Company's Quarterly Report on Form 10-Q for the three months ended March 31, 2025 (the '10-Q') was not filed with the Securities and Exchange Commission (the 'SEC') by the required due date of May 15, 2025." Based on this news, shares of Zeo fell by more than 9.9% on May 30, 2025. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Business Wire
37 minutes ago
- Business Wire
WOOF Investors Have Opportunity to Join Petco Health and Wellness Company, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Petco Health and Wellness Company, Inc. ('Petco' or 'the Company') (NASDAQ: WOOF) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Petco reported its financial results for Q1 2025 on June 5, 2025. The Company disclosed net sales of $1.5 billion, representing a 2.3% decline year-over-year. Based on this news, shares of Petco fell by more than 23.3% on June 6, 2025. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Business Wire
38 minutes ago
- Business Wire
QIPT Investors Have Opportunity to Join Quipt Home Medical Corp. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quipt Home Medical Corp. ('Quipt' or 'the Company') (NASDAQ: QIPT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. One of Quipt's largest shareholders, Forager Capital Management ("Forager"), issued a press release on June 5, 2025, requesting that the Company 'immediately and unequivocally retract its false and misleading statement made in its press release on May 21, 2025 relating to Forager's offer to acquire 100% of Quipt's issued and outstanding common shares at a price of $3.10 per common share." Based on this news, shares of Quipt fell by more than 8.5% on the same day. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
